https://www.cancerconference.gr/wp-content/uploads/2021/09/farmakis-320x320.jpg
Αναπληρωτής Καθηγητής Καρδιολογίας, Πανεπιστήμιο Κύπρου

Δημήτριος Φαρμάκης


Dimitrios Farmakis, MD, PhD, FESC, FHFA, is an Associate Professor at the University of Cyprus Medical School, head of Physiology Lab, director of the Basic Sciences and Basic Medical Sciences Undergraduate Program (“Phases I & II”) and consultant cardiologist at Nicosia General Hospital.

He graduated from the National and Kapodistrian University of Athens Medical School and received his doctoral degree from the same institution. He specialized in Cardiology at Athens University Hospital “Attikon” and was further trained in heart failure at Zurich University Hospital, Switzerland, in Cardio-Oncology at Bern University Hospital “Inselspital”, Switzerland, and in Clinical Trials at Harvard Medical School, Boston, USA.

His research fields include heart failure, cardio-oncology and hemoglobinopathy-associated heart disease. He has published 279 articles, of which 243 in PubMed journals (total impact factor, 1833; total citations, 11214; h index, 56). He has served as principal investigator and member of executive and steering committees in national and international trials and research projects and has received research grants and scholarships.

He has a long teaching experience at under- and post-graduate level at the National and Kapodistrian University of Athens, the European University Cyprus and the University of Cyprus and he is faculty of the European Heart Failure Training Program run by the University of Zurich and the European Society of Cardiology (ESC) Heart Failure Association (HFA). He has further been invited as a speaker to more than 200 congresses and authored 68 chapters in medical textbooks.

He sits on national and international scientific committees, guideline taskforces (including the 2021 ESC guidelines for heart failure) and expert panels. He is the Chairman of the ESC HFA Working Group on Atrial Disease, member of the Board of ESC Council of Cardio-Oncology, member of ESC HFA Study Group on Cardio-Oncology, member of the Steering Committee of the Working Group on Cardio-Oncology of the Hellenic Society of Cardiology (HSC), member of ESC Study Group on Cardiovascular Pharmacotherapy, former President of the HSC Working Group on Cardiomyopathies and Basic Research and former member of the Board and Treasurer of the Hellenic College of Cardiology.

He has received awards from national and international organizations, such as the National and Kapodistrian University of Athens Medical School (first award of excellence for the doctoral thesis), University of Patras Medical School (distinguished young cardiologist award), Harvard Medical School (distinction for the capstone project proposal), American Heart Association, United Arab Emirates Government and others.